“Passing on the richness of the Japanese language to the future.” Supporting a society that values human-written text in the age of AI.

Our company supports 'April Dream,' an initiative to make April 1st a day to share dreams. This press release is the dream of 'wordrabbit.' Remedies Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Tsuyoshi Fukuzawa) is participating in April Dream, which turns April 1st into a day to talk about dreams. Our dream is to pass on the richness of the Japanese language to the next generation by respecting the words written by people, and by supporting a society where everyone can use technology as an ally to accurately express their thoughts, especially in an era where AI generates text. We want to support three fields with our technology: 1. Delivering important books: Reducing the burden on the publishing industry. Creating a book involves meticulous manual work. 'wordrabbit' automates part of the verification process, allowing professional editors to focus on deeper content and creative work. 2. Connecting across barriers: The 'Sakubun-Jaws' companion. Today, we released 'Sakubun-Jaws,' a Japanese writing correction and evaluation system for foreigners, developed jointly with the University of Tsukuba and the National Institute for Japanese Language and Linguistics. It helps learners notice and correct mistakes themselves. 3. Nurturing the Japanese of the future: Supporting children's 'writing skills.' We aim to use our proofreading technology in education to reduce teachers' burdens and provide children with more opportunities to write and review their work. We want to be a 'reliable tool' that gently catches mistakes and supports expression for everyone who writes, creating a society where clear Japanese circulates. About 'wordrabbit': An AI solution specialized in Japanese proofreading that enhances professional quality control. About Remedies Inc.: An AI startup specializing in Japanese-language solutions based on proprietary technology. Finalist in 'IVS LaunchPad' 2024 and selected for 'APT Women' 2025.